Big Pharma & Start-ups: only the best in Alsace!
Alsace's health and life sciences companies all have one thing in mind: INNOVATE. Small business or large company, their momenta converge to create optimal conditions for everyone at the heart of the famous BioValley of France, Germany and Switzerland. Discover the names which are growing Alsace's world renown.
The world leaders are established in Alsace!
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Cutting edge start-ups!
Just a few examples of local talents:
 |
CellProthera is revolutionizing treatment for heart attack victims, thanks to an automated technique to produce regenerative cardiac tissue cells after myocardial infarction. CellProthera's unprecedented therapy is the product of the highest calibre scientific expertise.
|
 |
Firalis specializes in the identification and development of biomarkers for clinical use. Established in 2008, Firalis created a European consortium composed of 22 partners, including 11 pharmaceutical companies, to pursue the development of biomarkers to measure renal, hepatic and cardiovascular toxicity caused by medicines. Firalis aims to become a world leader in the production of diagnostic kits for the early detection of medicinal side-effects.
|
|
|
Starting with the innovative material, porous titanium, Protip has created a complete range of implants and prosthetic devices for the ENT, dental and orthopaedic sectors. Protip is currently developing an artificial larynx to restore throat cancer patients' lives without the traumatic effects of tracheotomy.
|
|
|
Established in 2008, Innovative Health Diagnostics (IHD) has perfected the diagnosis of Alzheimer's disease using blood biomarkers. This major breakthrough is a low-cost non-invasive procedure that offers 95% reliable results, using just a few drops of blood. Early detection on a massive scale is now possible in the fight against this disease that affects nearly 30 million people throughout the world.  www.ihdiag.com |
 |
Axilum Robotics is a spin-off company from the medical robotics research group of LSIIT, a joint research unit of the University of Strasbourg, CNRS and INSA Strasbourg. Its mission is to develop and commercialize dedicated robotized solutions to assist health care professionals with medical procedures. The first product of AXILUM ROBOTICS is a robot designed to assist psychiatrists and neurologists for Transcranial Magnetic Stimulation, a noninvasive procedure for the treatment of various neurological and psychiatric disorders. |
 |
Defymed mission is to develop and market implantable bio-artificial medical devices for various therapeutic applications including liver, kidney, neurological and endocrine diseases. The first company product is MAILPAN (MAcro-encapsulation of PANcreatic islets), a bio-artificial pancreas which has the potential to restore the physiological secretion of insulin in type 1 diabetes patients. Defymed is a spin-off of the Strasbourg-based CeeD (Centre européen d’études du Diabète) Research Institute.Learn more |
 |
Rhenovia Pharma is a service pharmaceuticals and biotechnology company.
They provide new solutions to discover new medicines against Alzheimer's and other central nervous system (CNS) diseases by: |
 |
VIRONEXX aims to become a key player in the creation of innovative approaches for the prevention and therapy of viral infections.
With its initial programs, VIRONEXX will focus on the development of unique and innovative biological compounds for the prevention and treatment of chronic HCV infection – a major cause of liver cirrhosis and liver cancer worldwide. Addressing the limitations of standard of care and novel therapies, VIRONEXX will first focus on the development of monoclonal antibodies targeting essential host entry factors. |
 |
UROLEAD is a preclinical CRO offering tumorgraft-based services in the urologic sphere : kidney, prostate, bladder. UROLEAD provices the pharmaceutical and biopharmaceutical industries with a unique experimental research platform combining both in vivo pharmacological models and in vitro assays, using human urologic tumors xenografted in nude mice. UROLEAD has a large collection of patient-derived urologic tumors representing the heterogeneity of these cancers; this collection is in continuous growth, and various characterizations and validations studies are performed on its preclinical models.www.urolead.com |
Facts & Figures
France's smallest region (3,166 mi²), Alsace is home to no less than 390 companies employing 26,400 people.
- Alsace's medical technology sector (medical equipment, imaging, robotics, surgery) represents:
260 companies
8,400 employees
6 research labs
12 research teams involving 700 people
- Its pharmaceutical sector represents:
130 companies
18 000 employees
20 research labs
31 research teams involving 1,200 people
These figures account for all actors in the chain (from conception in R&D to distribution)
E-newsletter
